C4 Therapeutics
CCCC
CCCC
92 hedge funds and large institutions have $267M invested in C4 Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more call options, than puts
Call options by funds: $7.75M | Put options by funds: $6.76M
11% more funds holding
Funds holding: 83 → 92 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
92
Holding in Top 10
1
Calls
$7.75M
Puts
$6.76M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$21.5M | |
| 3 | +$12M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$9.63M |
Top Sellers
| 1 | -$5.34M | |
| 2 | -$4.84M | |
| 3 | -$4.32M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$3.7M |
| 5 |
Two Sigma Advisers
New York
|
-$3.58M |